Other News

TR-1: Standard form for notification of major holdings   Please click here to read in full...

TR-1: Standard form for notification of major holdings   Please click here to read in full...

Physiomics plc (AIM: PYC), a leading mathematical modelling and data science company supporting the development of new therapeutics and personalised medicine solutions, today announces its unaudited financial results for the six months ended 31 December 2023.   Please click here to read in full....

11th of February was the International Day of Women and Girls in Science. On a day that was created to promote equal representation and gender equality in the science, technology, engineering and mathematics (STEM) disciplines, Physiomics are proud to have a team of scientist that is made up of 50% women. To mark the occasion, we have taken the opportunity to celebrate and get to...

Physiomics plc (AIM: PYC), the oncology consultancy using mathematical models to support the development of cancer treatment regimens and personalised medicine solutions, is pleased to provide notice of the Company’s Annual General Meeting (“AGM”).   The AGM will be held at 10.30 a.m. on 21 November 2023 at the Company’s new registered office, Bee House, 140 Eastern Avenue, Milton Park, Oxfordshire, OX14 4SB.   Shareholders will shortly be sent...

Physiomics plc (AIM: PYC), a leading mathematical modelling company, supporting development of oncology drugs and personalised medicine solutions, is pleased to announce that it has been awarded its first contract with a new UK-based biotech client.  The contract, which has a value of £125,000 and relates to a project in the immune-oncology field, is expected to be completed within this calendar year. Physiomics CEO, Dr Jim...